{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:06:59Z","timestamp":1790784419123,"version":"4.1.0"},"reference-count":59,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"abstract":"\n Importance<\/jats:title>\n Understanding spending on mental health could help inform policymakers on decisions about where to direct mental health care resources and help evaluate whether spending aligns with public health priorities. Despite this, the magnitude and distribution of mental health expenditures in the US remain poorly characterized.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate aggregate mental health expenditures by sociodemographic characteristics, type of insurance, mental health disorders, and type of service.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a cross-sectional analysis of the 2021-2023 Medical Expenditure Panel Survey (MEPS), an annual, nationally representative survey of the civilian noninstitutionalized US population. Analyses focused on individuals who made at least 1 outpatient mental health visit in 2021, 2022, or 2023. Data analysis was conducted from August 2025 to January 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Outpatient mental health visits.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Overall and per-100-person expenditures stratified by sociodemographic characteristics and diagnostic categories.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The analysis included all survey participants (N\u2009=\u200967\u202f532 person-year observations; mean [SD] age, 39.8 [0.25] years; 35\u202f608 [50.7%] female) and identified those with reported outpatient mental health visits in 2021, 2022, and 2023 (n\u2009=\u200915\u202f407; mean [SD] age, 45.0 [0.36] years; 9500 [60.0%] female). The estimated annualized aggregate total health care expenditures as measured in the MEPS in 2021-2023 were $2.5 trillion (95% CI, $2.3 trillion to $2.7 trillion), with $174 billion (95% CI, $152 billion to $196 billion) in mental health expenditures representing 7.0% (95% CI, 6.4%-7.7%) of all medical expenditures. This represented an annual mean of $523 (95% CI, $474-$571) per person overall and $2473 (95% CI, $2266-$2679) per person among those with any treated mental health disorder. Mood disorders and anxiety and fear-related disorders accounted for the highest aggregate expenditures ($74 billion [95% CI, $62 billion to $86 billion] and $69 billion [95% CI, $58 billion to $81 billion], respectively). Expenditures per treated individual were highest for substance use disorders ($9569 [95% CI, $6943-$12\u202f195]), schizophrenia ($9370 [95% CI, $6685-$12\u202f055]), and bipolar disorders ($7382 [95% CI, $6027-$8737]). Overall, expenditures on ambulatory services accounted for $107 billion (95% CI, $93 billion to $121 billion), while expenditures on medication accounted for $36 billion (95% CI, $31 billion to $40 billion) and those for home health care and inpatient treatment accounted for $20 billion (95% CI, $11 billion to $29 billion) and $12 billion (95% CI, $8 billion to $15 billion), respectively.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cross-sectional study found that expenditures on mental health disorders in the US vary widely at the per-person and population levels, but they are consistently low relative to the societal burden of mental disorders. Research that leads to more effective treatments, decreases provision of low-value care, and supports better matching of patients\u2019 impairment with the appropriate level of care could help optimize treatment access while controlling expenditures.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.3120","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:31:33Z","timestamp":1790782293000},"source":"Crossref","is-referenced-by-count":0,"title":["Mental Health and Substance Use Disorder Expenditures in the US"],"prefix":"10.1001","author":[{"given":"Carlos","family":"Blanco","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler","family":"McClellan","sequence":"additional","affiliation":[{"name":"Agency for Healthcare Research and Quality, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Zuvekas","sequence":"additional","affiliation":[{"name":"Agency for Healthcare Research and Quality, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"6","key":"yoi260046r1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archpsyc.62.6.603","article-title":"Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Wang","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"yoi260046r2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.4088\/JCP.13m08361","article-title":"Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"74","author":"Iza","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"yoi260046r3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugalcdep.2015.01.031","article-title":"Probability and predictors of treatment-seeking for substance use disorders in the U.S.","volume":"149","author":"Blanco","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"yoi260046r4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1017\/S0033291710002291","article-title":"Barriers to mental health treatment: results from the National Comorbidity Survey Replication.","volume":"41","author":"Mojtabai","year":"2011","journal-title":"Psychol Med"},{"issue":"5","key":"yoi260046r5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/jamapediatrics.2025.0007","article-title":"Opportunities and needs to advance prevention of substance use disorders.","volume":"179","author":"Blanco","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"4","key":"yoi260046r6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1377\/hlthaff.2025.01351","article-title":"US national spending on mental health and substance use disorder treatment driven by case growth, 2000-21.","volume":"45","author":"Mark","year":"2026","journal-title":"Health Aff (Millwood)"},{"issue":"10469","key":"yoi260046r7","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/S0140-6736(24)01446-6","article-title":"The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"404","author":"GBD 2021 US Burden of Disease Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"yoi260046r12","first-page":"3","article-title":"Measuring disparities across the distribution of mental health care expenditures.","volume":"16","author":"L\u00ea Cook","year":"2013","journal-title":"J Ment Health Policy Econ"},{"issue":"2","key":"yoi260046r14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/1475-6773.14115","article-title":"Using machine-learning algorithms to improve imputation in the Medical Expenditure Panel Survey.","volume":"58","author":"McClellan","year":"2023","journal-title":"Health Serv Res"},{"issue":"3","key":"yoi260046r16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/M23-2824","article-title":"Trends in psychological distress and outpatient mental health care of adults during the COVID-19 era.","volume":"177","author":"Olfson","year":"2024","journal-title":"Ann Intern Med"},{"issue":"2","key":"yoi260046r17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.0006-341X.2000.00645.x","article-title":"A note on robust variance estimation for cluster-correlated data.","volume":"56","author":"Williams","year":"2000","journal-title":"Biometrics"},{"issue":"12","key":"yoi260046r18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jama.2024.26790","article-title":"Tracking US health care spending by health condition and county.","volume":"333","author":"Dieleman","year":"2025","journal-title":"JAMA"},{"issue":"3","key":"yoi260046r19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1176\/appi.ps.201700271","article-title":"Differential reimbursement of psychiatric services by psychiatrists and other medical providers.","volume":"69","author":"Mark","year":"2018","journal-title":"Psychiatr Serv"},{"key":"yoi260046r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108385","article-title":"Research on substance use disorders during the COVID-19 pandemic.","volume":"129","author":"Volkow","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"yoi260046r21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2021.3136","article-title":"Expanding current approaches to solve the opioid crisis.","volume":"79","author":"Blanco","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"yoi260046r22","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/jamainternmed.2024.3422","article-title":"Addiction consultation services for opioid use disorder treatment initiation and engagement: a randomized clinical trial.","volume":"184","author":"McNeely","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"2","key":"yoi260046r23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2024.5756","article-title":"Management of depression in adults: a review.","volume":"332","author":"Simon","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"yoi260046r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021.","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"yoi260046r27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chc.2020.05.001","article-title":"Regulators, payors, and the impact of measurement-based care on value-based care in psychiatry.","volume":"29","author":"Axelson","year":"2020","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"yoi260046r28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/NMD.0000000000000117","article-title":"Effect of first episode axis I disorders on quality of life.","volume":"202","author":"Rubio","year":"2014","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"yoi260046r29","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.4088\/JCP.12m08269","article-title":"Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"74","author":"Rubio","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"13","key":"yoi260046r30","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"yoi260046r31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey.","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"yoi260046r32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/mp.2008.41","article-title":"Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"14","author":"Grant","year":"2009","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi260046r33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamapsychiatry.2013.281","article-title":"Mapping common psychiatric disorders: structure and predictive validity in the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"70","author":"Blanco","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yoi260046r34","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1017\/S003329171700054X","article-title":"Examining heterotypic continuity of psychopathology: a prospective national study.","volume":"47","author":"Blanco","year":"2017","journal-title":"Psychol Med"},{"issue":"3","key":"yoi260046r35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1360-0443.2010.03194.x","article-title":"Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"106","author":"Lopez-Quintero","year":"2011","journal-title":"Addiction"},{"issue":"12","key":"yoi260046r36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jpsychires.2011.08.004","article-title":"Predictors of persistence of social anxiety disorder: a national study.","volume":"45","author":"Blanco","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"1","key":"yoi260046r37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jad.2013.06.013","article-title":"Persistence of chronic major depression: a national prospective study.","volume":"151","author":"Garcia-Toro","year":"2013","journal-title":"J Affect Disord"},{"issue":"11","key":"yoi260046r38","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2014.1206","article-title":"Testing the drug substitution switching-addictions hypothesis: a prospective study in a nationally representative sample.","volume":"71","author":"Blanco","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"yoi260046r39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpsychires.2017.07.022","article-title":"A comprehensive model of predictors of persistence and recurrence in adults with major depression: results from a national 3-year prospective study.","volume":"95","author":"Hoertel","year":"2017","journal-title":"J Psychiatr Res"},{"issue":"5","key":"yoi260046r40","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13778","article-title":"A comprehensive model of predictors of recurrence or persistence in individuals with panic disorder: results from a national 3-year prospective study.","volume":"83","author":"Scheer","year":"2022","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"yoi260046r42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamapsychiatry.2018.3550","article-title":"Trends in serious psychological distress and outpatient mental health care of US adults.","volume":"76","author":"Olfson","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi260046r43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamapsychiatry.2018.3329","article-title":"Implementing measurement-based care in behavioral health: a review.","volume":"76","author":"Lewis","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"yoi260046r44","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03738-6","article-title":"A population-level approach to the treatment of psychiatric disorders.","author":"Blanco","journal-title":"Mol Psychiatry"},{"issue":"3","key":"yoi260046r45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jamapsychiatry.2025.4308","article-title":"Prospects of GLP-1 therapies for addiction and mental health comorbidities\u2014quo vadis?: a review.","volume":"83","author":"Farokhnia","year":"2026","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi260046r46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/add.16626","article-title":"GLP-1R agonist medications for addiction treatment.","volume":"120","author":"Volkow","year":"2025","journal-title":"Addiction"},{"issue":"1","key":"yoi260046r47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/wps.21160","article-title":"The social determinants of mental health and disorder: evidence, prevention and recommendations.","volume":"23","author":"Kirkbride","year":"2024","journal-title":"World Psychiatry"},{"issue":"8","key":"yoi260046r48","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1017\/S0033291721005468","article-title":"Toward a generalized developmental model of psychopathological liabilities and psychiatric disorders.","volume":"53","author":"Blanco","year":"2023","journal-title":"Psychol Med"},{"issue":"23","key":"yoi260046r49","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1001\/jama.2022.6469","article-title":"From scientific discovery to covered treatments: understanding the payer perspective as a keystone to achieving high-value care.","volume":"327","author":"Blanco","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"yoi260046r50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/1475-6773.13311","article-title":"Public insurance expansions and mental health care availability.","volume":"55","author":"Blunt","year":"2020","journal-title":"Health Serv Res"},{"issue":"1","key":"yoi260046r51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/689772","article-title":"In the shadow of a giant: Medicare\u2019s influence on private physician payments.","volume":"125","author":"Clemens","year":"2017","journal-title":"J Polit Econ"},{"key":"yoi260046r52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2022.102624","article-title":"Trading spaces: Medicare\u2019s regulatory spillovers on treatment setting for non-Medicare patients.","volume":"84","author":"Geruso","year":"2022","journal-title":"J Health Econ"},{"issue":"2","key":"yoi260046r55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1176\/appi.ajp.20250629","article-title":"Coding inequities in psychiatric care: a call to align DSM\/ICD with chronic disease management.","volume":"183","author":"Bystritsky","year":"2026","journal-title":"Am J Psychiatry"},{"issue":"22","key":"yoi260046r56","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1056\/NEJMp2513434","article-title":"Has corporatization met its match? the challenge of making money by keeping people healthy.","volume":"393","author":"Cutler","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"yoi260046r57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5034\/inquiryjrnl_46.01.92","article-title":"Accuracy of Medicare expenditures in the Medical Expenditure Panel Survey.","volume":"46","author":"Zuvekas","year":"2009","journal-title":"Inquiry"},{"issue":"6","key":"yoi260046r58","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/1077558715592745","article-title":"Assessing the representativeness of Medical Expenditure Panel Survey inpatient utilization data for individuals with psychiatric and nonpsychiatric conditions.","volume":"72","author":"Slade","year":"2015","journal-title":"Med Care Res Rev"},{"key":"yoi260046r9","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"yoi260046r26","volume-title":"Blueprint for a National Prevention Infrastructure for Mental, Emotional, and Behavioral Disorders","author":"National Academies of Sciences, Engineering, and Medicine","year":"2025"},{"key":"yoi260046r41","volume-title":"Geographic Variation in Inpatient Stays for Five Leading Mental Disorders, 2016-2018","author":"Fingar","year":"2022"},{"key":"yoi260046r54","volume-title":"The Improvement Guide: A Practical Approach to Enhancing Organizational Performance","author":"Langley","year":"2009"},{"key":"yoi260046r59","volume-title":"Reconciling Medical Expenditure Estimates From the MEPS and NHEA, 2012","author":"Bernard","year":"2017"},{"key":"yoi260046r8","unstructured":"US Bureau of Economic Analysis. Health care. Updated August 2024. Accessed December 2, 2025. https:\/\/www.bea.gov\/data\/special-topics\/health-care"},{"key":"yoi260046r10","unstructured":"Agency for Healthcare Research and Quality. Accounting for clustering in the analysis of MEPS data: frequently asked questions. Accessed February 26, 2025. https:\/\/meps.ahrq.gov\/survey_comp\/hc_clustering_faq.pdf"},{"key":"yoi260046r11","unstructured":"Office of the Assistant Secretary for Planning and Evaluation. Poverty guidelines. Accessed December 2, 2025. https:\/\/aspe.hhs.gov\/topics\/poverty-economic-mobility\/poverty-guidelines"},{"key":"yoi260046r13","unstructured":"Agency for Healthcare Research and Quality. Clinical Classifications Software Refined (CCSR) for ICD-10-CM diagnoses. Updated 2024. Accessed September 1, 2026. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/dxccsr.jsp"},{"key":"yoi260046r15","unstructured":"Bernard? D, Selden? TM, Pylypchuk? YO. Aligning the Medical Expenditure Panel Survey to Aggregate U.S. Benchmarks, 2010. Agency for Healthcare Research and Quality. January 2015. Accessed June 8, 2026. https:\/\/meps.ahrq.gov\/data_files\/publications\/workingpapers\/wp_15002.pdf"},{"key":"yoi260046r24","unstructured":"Substance Abuse and Mental Health Services Administration. 2023 NSDUH Annual National Report. 2024. Accessed December 2, 2025. https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\/national-releases\/2023"},{"key":"yoi260046r53","unstructured":"National Institutes of Health. Actual total obligations by institute and center. 2025. Accessed March 12, 2025. https:\/\/officeofbudget.od.nih.gov\/pdfs\/FY26\/spending_hist\/Actual%20Obligations%20by%20IC%20FY%202000%20-%20FY%202024%20(V).pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2854488\/jamapsychiatry_blanco_2026_oi_260046_1789677286.00816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:31:37Z","timestamp":1790782297000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2854488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.3120","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}